๐ŸŽ—๏ธ OncologyInjection (SC)

    Epkinly

    Epcoritamab

    CD20-CD3 bispecific antibody administered subcutaneously for relapsed/refractory DLBCL.

    Form

    Injection (SC)

    Uses

    2

    Side effects

    5

    Category

    Oncology

    01

    What is Epkinly used for?

    • Relapsed/refractory diffuse large B-cell lymphoma
    • Large B-cell lymphoma
    02

    Epcoritamab side effects

    Common side effects of Epcoritamab include:

    Cytokine release syndrome
    Fatigue
    Injection site reactions
    Musculoskeletal pain
    ICANS
    CommonModerateLess common
    03

    Epcoritamab warnings & precautions

    • Black box: CRS and neurologic toxicity (ICANS)
    • REMS program
    • Step-up dosing required

    Loading FDA dataโ€ฆ

    04

    Frequently asked questions

    05

    Related medications

    Share

    Share this drug info.

    Help friends and family understand Epkinly in plain language.

    Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.